Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 875 shares at $6.75 ($5K) on 2025-03-05, disclosed to the SEC on 2025-04-04.
Scheduled purchase ($5k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.54 | 47 | $260 | 5.7% |
| 2 | $5.11 | 47 | $240 | 5.3% |
| 3 | $6.75 | 47 | $317 | 7.0% |
| 4 | $6.57 | 47 | $309 | 6.8% |
| 5 | $6.51 | 47 | $306 | 6.7% |
| 6 | $5.85 | 37 |
| $216 |
| 4.8% |
| 7 | $4.85 | 37 | $179 | 3.9% |
| 8 | $5.17 | 37 | $191 | 4.2% |
| 9 | $5.47 | 37 | $202 | 4.4% |
| 10 | $5.38 | 37 | $199 | 4.4% |
| 11 | $5.41 | 37 | $200 | 4.4% |
| 12 | $5.12 | 37 | $189 | 4.2% |
| 13 | $5.41 | 37 | $200 | 4.4% |
| 14 | $5.07 | 37 | $188 | 4.1% |
| 15 | $4.89 | 37 | $181 | 4.0% |
| 16 | $4.42 | 45 | $199 | 4.4% |
| 17 | $4.45 | 45 | $200 | 4.4% |
| 18 | $4.41 | 45 | $198 | 4.4% |
| 19 | $4.20 | 45 | $189 | 4.2% |
| 20 | $4.20 | 45 | $189 | 4.2% |
| 21 | $4.29 | 45 | $193 | 4.2% |
| Total | $5.20 avg | 875 | $5K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |